Skip to search formSkip to main contentSkip to account menu

Levetiracetam

Known as: (S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide, 1-Pyrrolidineacetamide, Alpha-ethyl-2-oxo-,(S)-, etiracetam, S-isomer 
A pyrrolidine with antiepileptic activity. The exact mechanism through which levetiracetam exerts its effects is unknown but does not involve… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Antiseizure drugs (ASDs) are known to cause a wide range of adverse drug reactions (ADRs). Recently, electronic health care data… 
2009
2009
Dyskinetic cerebral palsy (CP) is a movement disorder that is difficult to treat and which causes major disability. We report on… 
2008
2008
Prophylactic Treatment with Levetiracetam after Status Epilepticus: Lack of Effect on Epileptogenesis, Neuronal Damage, and… 
2006
2006
The aim of this study was to assess the relationship between levetiracetam dose and both efficacy and safety in adult patients… 
2004
2004
Summary:  We report a patient with focal epilepsy and latent hereditary coproporphyria who had exacerbation of clinical symptoms… 
2003
2003
[reaction: see text] An efficient asymmetric synthesis of the vasopeptidase inhibitor BMS-189921 was accomplished. Two short… 
2003
2003
Lithiation and alkylation of a 2-isopropylidineaziridine bearing an (S)-alpha-methylbenzyl group on nitrogen proceeds with high… 
1999
1999
Deltamethrin (S)-alpha-cyano-3-phenoxybenzyl) (1R,3R)-3-(2, 2-dibromovinyl)-2,2-dimethylcyclopropane-1-carboxylate is classified… 
1991
1991
The involvement of histaminergic neurons in the neuroendocrine regulation of the release of the pro-opiomelanocortin-derived…